Clearmind Gains IRB Approval At TASMC For Alcohol Use Disorder Drug Trial July 03, 2025 — 01:23 pm EDT Written by RTTNews.com for RTTNews -> ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

Clearmind Medicine gets IRB nod from TASMC for phase 1/2a clinical trial to evaluate CMND-100 for treatment of alcohol use disorder: Vancouver, Canada Saturday, July 5, 2025, 18:0 ...

A new care center for homeless people on Los Angeles' infamous Skid Row embraces the principle of harm reduction, a more ...

The Drugs Consultative Committee (DCC) has agreed to amend the Drugs Rules, 1945 to regulate the alcohol content in tinctures ...

Generic Ablysinol is indicated for the induction of controlled cardiac septal infarction to improve exercise capacity in adult patients with hypertrophic obstructive cardiomyopathy.

Dr. Santina Wheat, Family Medicine Physician at Northwestern Medicine Delnor Hospital in Geneva joins Bob Sirott to cover a ...

A motorcyclist was fatally struck by a car on Airline Drive, and now the driver has been arrested for possible impairment.

Aldeyra's Reproxalap progresses towards FDA approval, with a potential $100M AbbVie deal. There’s still upside potential, ...

Atai Life Sciences is making incremental progress towards opening door for a first psychedelic treatment for depression. Read ...

On July 5, 2025, at approximately 5:30 p.m., Troopers from Louisiana State Police Troop G responded to a three-vehicle crash ...

President Donald Trump‘s sign-off on Florida’s plan to deputize the National Guard to serve as immigration judges is the ...